179 related articles for article (PubMed ID: 8561501)
1. Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1996 Jan; 325(2):227-34. PubMed ID: 8561501
[TBL] [Abstract][Full Text] [Related]
2. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1995 Jan; 316(1):290-301. PubMed ID: 7530937
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric oxide synthase isoforms by porphyrins.
Wolff DJ; Naddelman RA; Lubeskie A; Saks DA
Arch Biochem Biophys; 1996 Sep; 333(1):27-34. PubMed ID: 8806750
[TBL] [Abstract][Full Text] [Related]
4. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
Reif DW; McCreedy SA
Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas.
Wolff DJ; Gauld DS; Neulander MJ; Southan G
J Pharmacol Exp Ther; 1997 Oct; 283(1):265-73. PubMed ID: 9336332
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adducts.
Wolff DJ; Papoiu AD; Mialkowski K; Richardson CF; Schuster DI; Wilson SR
Arch Biochem Biophys; 2000 Jun; 378(2):216-23. PubMed ID: 10860539
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
[TBL] [Abstract][Full Text] [Related]
9. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
Cooper GR; Barr A; Wolff DJ
Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
[TBL] [Abstract][Full Text] [Related]
10. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
Cooper GR; Mialkowski K; Wolff DJ
Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
[TBL] [Abstract][Full Text] [Related]
11. Oxygen-induced radical intermediates in the nNOS oxygenase domain regulated by L-arginine, tetrahydrobiopterin, and thiol.
Berka V; Wang LH; Tsai AL
Biochemistry; 2008 Jan; 47(1):405-20. PubMed ID: 18052254
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase activity in Fasciola hepatica: a radiometric study.
Terenina NB; Onufriev MV; Gulyaeva NV; Moiseeva YV; Gustafsson MK
Parasitology; 2003 Jun; 126(Pt 6):585-90. PubMed ID: 12866797
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of the flavin semiquinone of nitric oxide synthase in the oxygenation of arginine to NG-hydroxyarginine, the first step of nitric oxide synthesis.
Witteveen CF; Giovanelli J; Yim MB; Gachhui R; Stuehr DJ; Kaufman S
Biochem Biophys Res Commun; 1998 Sep; 250(1):36-42. PubMed ID: 9735327
[TBL] [Abstract][Full Text] [Related]
14. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
Bryk R; Lubeskie A; Wolff DJ
Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
[TBL] [Abstract][Full Text] [Related]
15. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES
J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of neuronal nitric oxide synthase by N omega-nitroarginine-and phenylalanine-containing dipeptides and dipeptide esters.
Silverman RB; Huang H; Marletta MA; Martasek P
J Med Chem; 1997 Aug; 40(18):2813-7. PubMed ID: 9288162
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of neuronal nitric oxide synthase enzyme in early-phase isoflurane-induced hypotension in rats.
Ellenberger EA; Lucas HL; Mueller JL; Barrington PL; Chung E; Ohgami Y; Quock RM
Life Sci; 2004 Dec; 76(5):499-507. PubMed ID: 15556163
[TBL] [Abstract][Full Text] [Related]
18. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
Chabin RM; McCauley E; Calaycay JR; Kelly TM; MacNaul KL; Wolfe GC; Hutchinson NI; Madhusudanaraju S; Schmidt JA; Kozarich JW; Wong KK
Biochemistry; 1996 Jul; 35(29):9567-75. PubMed ID: 8755738
[TBL] [Abstract][Full Text] [Related]
19. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.
Babu BR; Griffith OW
J Biol Chem; 1998 Apr; 273(15):8882-9. PubMed ID: 9535869
[TBL] [Abstract][Full Text] [Related]
20. Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization.
Gorren AC; Schrammel A; Schmidt K; Mayer B
Biochemistry; 1997 Apr; 36(14):4360-6. PubMed ID: 9100033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
